Accent Therapeutics Contact Us
Accent Therapeutics Logo
Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.
- Website
- Directions
WEBMar 21, 2024 · Accent Therapeutics to Present Data Supporting DHX9 and KIF18A as Compelling Therapeutic Targets at American Association for Cancer Research (AACR) Annual Meeting 2024. READ News. 1050 Waltham St., Suite 201 Lexington, MA 02421. …
See Also: Contact Support Preview / Show details
News and Events accenttx.com
WEBOct 10, 2023 · JOIN US; 1050 Waltham St., Suite 201 Lexington, MA 02421 Tel: (339) 970-7400. News. 4.8.24. Accent Therapeutics Presents Data Supporting Two Lead …
See Also: Support Number Preview / Show details
Small molecule therapies with accenttx.com
WEBAccent is developing first-in-class small molecule inhibitors of ADAR1, a historically challenging, high-value oncology target with substantial opportunity for use as a …
See Also: Phone Number Preview / Show details
Accent Therapeutics Translating extraordinary science into life
WEBJan 23, 2024 · "These additional resources position us well to file INDs this year for both our DHX9 and KIF18A programs, and to rapidly progress them through early clinical …
See Also: Phone Number Preview / Show details
Become an accenttx.com
WEBWe encourage you to contact us for more information or to submit your resume: [email protected]. Check back here often for the latest job openings at Accent. …
See Also: Contact Support Preview / Show details
Accent Therapeutics Announces $75 Million Series C …
WEBJan 23, 2024 · /PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced …
See Also: Phone Number Preview / Show details
Accent Therapeutics, Inc. MassBio
WEBOverview. Accent’s approach integrates novel target space with the most successful approach to therapeutic intervention in the history of medicine: small, synthetic …
See Also: Phone Number Preview / Show details
Accent Therapeutics and AstraZeneca to Discover and …
WEBJun 4, 2020 · Accent will receive an upfront payment of $55 million and, in the event that Accent elects to jointly develop the nominated program, is eligible to receive up to $1.1 …
See Also: Phone Number Preview / Show details
Accent Therapeutics Translating extraordinary science into life
WEBPrior to joining Accent, Serena was Vice President of Discovery Biology and Technologies at Fulcrum Therapeutics, where she led scientific teams to develop and deploy new …
See Also: Tech Support Preview / Show details
Accent Therapeutics Company Profile Craft
WEBAccent Therapeutics has 5 employees at their 1 location and $103 m in total funding,. See insights on Accent Therapeutics including office locations, competitors, revenue, …
See Also: Office Preview / Show details
Accent Therapeutics Crunchbase Company Profile & Funding
WEBFounded Date 2017. Founders Robert A. Copeland. Operating Status Active. Last Funding Type Series C. Legal Name Accent Therapeutics, Inc. Company Type For Profit. …
See Also: Phone Number Preview / Show details
Accent Therapeutics Company Contact Information Email, Phone …
WEBGet Accent Therapeutics company's verified web address, revenue, total contacts 17, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io
See Also: Phone Number Preview / Show details
Accent Therapeutics Presents Data Supporting DHX9 Inhibition as …
WEBLEXINGTON, Mass., April 16, 2023 /PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company developing breakthrough, oncology-focused small molecule …
See Also: Support Number Preview / Show details
Accent Therapeutics Overview, News & Similar companies
WEBAccent Therapeutics Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting Robert A. Copeland, Chief Scientific Officer, to provide major …
See Also: Support Number Preview / Show details
Accent Therapeutics Company Profile 2024: Valuation, Funding
WEB18-May-2018. $40M. $40M. 000.00. Completed. Pre-Clinical Trials. To view Accent Therapeutics’s complete valuation and funding history, request access ».
See Also: Phone Number Preview / Show details
Accent Therapeutics to Present Data Supporting DHX9 and KIF18A …
WEBMar 21, 2024 · Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced four upcoming …
See Also: Support Number Preview / Show details
Accent Therapeutics Presents Data Supporting Two Lead Programs …
WEBApr 8, 2024 · Accent Therapeutics, Inc. Apr 08, 2024, 17:30 ET. Robert A. Copeland, Chief Scientific Officer, to provide major symposium presentation on inhibition of key …
See Also: Support Number Preview / Show details